CTIM-17. INDIVIDUALIZED MULTIMODAL IMMUNOTHERAPY (IMI) FOR ADULTS WITH DIFFUSE MIDLINE GLIOMA OR DIFFUSE HEMISPHERIC GLIOMA

Authors: Stefaan Van Gool, Jennifer Kosmal, Peter Van de Vliet, Linde Kampers, Wilfried Stücker

Published: 2024-11-11

DOI: 10.1093/neuonc/noae165.0350

Source: Full article